| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0001 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |